These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 30547685)
1. Correlation between sclerostin and Dickkopf-1 with aortic arterial stiffness in patients with type 2 diabetes: A prospective, cross-sectional study. Yang HY; Wu DA; Chen MC; Hsu BG Diab Vasc Dis Res; 2019 May; 16(3):281-288. PubMed ID: 30547685 [TBL] [Abstract][Full Text] [Related]
2. Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients. Chang YC; Hsu BG; Liou HH; Lee CJ; Wang JH BMC Cardiovasc Disord; 2018 Nov; 18(1):214. PubMed ID: 30482161 [TBL] [Abstract][Full Text] [Related]
3. Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study. Hsu BG; Liou HH; Lee CJ; Chen YC; Ho GJ; Lee MC Medicine (Baltimore); 2016 Apr; 95(15):e3300. PubMed ID: 27082570 [TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide-binding protein is associated with arterial stiffness in patients with type 2 diabetes: a cross-sectional study. Sakura T; Morioka T; Shioi A; Kakutani Y; Miki Y; Yamazaki Y; Motoyama K; Mori K; Fukumoto S; Shoji T; Emoto M; Inaba M Cardiovasc Diabetol; 2017 May; 16(1):62. PubMed ID: 28486964 [TBL] [Abstract][Full Text] [Related]
5. The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus. Gaudio A; Privitera F; Pulvirenti I; Canzonieri E; Rapisarda R; Fiore CE Diab Vasc Dis Res; 2014 Jan; 11(1):48-52. PubMed ID: 24227537 [TBL] [Abstract][Full Text] [Related]
6. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women. Hampson G; Edwards S; Conroy S; Blake GM; Fogelman I; Frost ML Bone; 2013 Sep; 56(1):42-7. PubMed ID: 23702386 [TBL] [Abstract][Full Text] [Related]
7. Increased Sclerostin, but Not Dickkopf-1 Protein, Is Associated with Elevated Pulse Wave Velocity in Hemodialysis Subjects. Stavrinou E; Sarafidis PA; Koumaras C; Loutradis C; Giamalis P; Tziomalos K; Karagiannis A; Papagianni A Kidney Blood Press Res; 2019; 44(4):679-689. PubMed ID: 31382263 [TBL] [Abstract][Full Text] [Related]
8. Plasma levels of the arterial wall protein fibulin-1 are associated with carotid-femoral pulse wave velocity: a cross-sectional study. Laugesen E; Høyem P; Christiansen JS; Knudsen ST; Hansen KW; Argraves WS; Hansen TK; Poulsen PL; Rasmussen LM Cardiovasc Diabetol; 2013 Jul; 12():107. PubMed ID: 23866070 [TBL] [Abstract][Full Text] [Related]
9. High normal albuminuria is independently associated with aortic stiffness in patients with Type 2 diabetes. Liu JJ; Tavintharan S; Yeoh LY; Sum CF; Ng XW; Pek SL; Lee SB; Tang WE; Lim SC; Diabet Med; 2014 Oct; 31(10):1199-204. PubMed ID: 24702136 [TBL] [Abstract][Full Text] [Related]
10. Sclerostin is a possible candidate marker of arterial stiffness: Results from a cohort study in Catania. Gaudio A; Fiore V; Rapisarda R; Sidoti MH; Xourafa A; Catalano A; Tringali G; Zanoli L; Signorelli SS; Fiore CE Mol Med Rep; 2017 May; 15(5):3420-3424. PubMed ID: 28339088 [TBL] [Abstract][Full Text] [Related]
11. Serum cystatin C is independently associated with aortic arterial stiffness in patients with type 2 diabetes. Su IM; Wu DA; Lee CJ; Hou JS; Hsu BG; Wang JH Clin Chim Acta; 2018 May; 480():114-118. PubMed ID: 29432710 [TBL] [Abstract][Full Text] [Related]
12. Serum Sclerostin But Not DKK-1 Correlated with Central Arterial Stiffness in End Stage Renal Disease Patients. Wu CF; Hou JS; Wang CH; Lin YL; Lai YH; Kuo CH; Liou HH; Tsai JP; Hsu BG Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32075016 [TBL] [Abstract][Full Text] [Related]
13. Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness. Thambiah S; Roplekar R; Manghat P; Fogelman I; Fraser WD; Goldsmith D; Hampson G Calcif Tissue Int; 2012 Jun; 90(6):473-80. PubMed ID: 22527202 [TBL] [Abstract][Full Text] [Related]
14. Serum leptin levels are positively associated with aortic stiffness in patients with chronic kidney disease stage 3-5. Lu JW; Chi PJ; Lin YL; Wang CH; Hsu BG Adipocyte; 2020 Dec; 9(1):206-211. PubMed ID: 32403968 [TBL] [Abstract][Full Text] [Related]
15. High serum adipocyte fatty acid binding protein concentration linked with increased aortic arterial stiffness in patients with type 2 diabetes. Tseng PW; Hou JS; Wu DA; Hsu BG Clin Chim Acta; 2019 Aug; 495():35-39. PubMed ID: 30928570 [TBL] [Abstract][Full Text] [Related]
16. Circulating Wnt/β-catenin signalling inhibitors and uraemic vascular calcifications. Yang CY; Chang ZF; Chau YP; Chen A; Yang WC; Yang AH; Lee OK Nephrol Dial Transplant; 2015 Aug; 30(8):1356-63. PubMed ID: 25817223 [TBL] [Abstract][Full Text] [Related]
17. Factors associated with serum soluble inhibitors of Wnt-β-catenin signaling (sclerostin and dickkopf-1) in patients undergoing peritoneal dialysis. Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Ooboshi H; Kitazono T Nephrology (Carlton); 2015 Sep; 20(9):639-45. PubMed ID: 25974190 [TBL] [Abstract][Full Text] [Related]
18. Elevation of a novel angiogenic factor, leucine-rich-α2-glycoprotein (LRG1), is associated with arterial stiffness, endothelial dysfunction, and peripheral arterial disease in patients with type 2 diabetes. Pek SL; Tavintharan S; Wang X; Lim SC; Woon K; Yeoh LY; Ng X; Liu J; Sum CF J Clin Endocrinol Metab; 2015 Apr; 100(4):1586-93. PubMed ID: 25636050 [TBL] [Abstract][Full Text] [Related]
19. The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus. Tentolouris A; Eleftheriadou I; Grigoropoulou P; Kokkinos A; Siasos G; Ntanasis-Stathopoulos I; Tentolouris N J Diabetes Complications; 2017 Nov; 31(11):1624-1629. PubMed ID: 28893495 [TBL] [Abstract][Full Text] [Related]
20. Increased levels of Dickkopf-1 are indicative of Wnt/β-catenin downregulation and lower osteoblast signaling in children and adolescents with type 1 diabetes mellitus, contributing to lower bone mineral density. Tsentidis C; Gourgiotis D; Kossiva L; Marmarinos A; Doulgeraki A; Karavanaki K Osteoporos Int; 2017 Mar; 28(3):945-953. PubMed ID: 27766367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]